메뉴 건너뛰기




Volumn 32, Issue 4, 2006, Pages 616-617

Introduction: Current research on co-occurring substance-use disorder in schizophrenia

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

EID: 33748765807     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbl020     Document Type: Editorial
Times cited : (4)

References (9)
  • 1
    • 20944446077 scopus 로고    scopus 로고
    • Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene 3 environment interaction
    • Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene 3 environment interaction. Biol Psychiatry. 2005;57:1117-1127.
    • (2005) Biol Psychiatry , vol.57 , pp. 1117-1127
    • Caspi, A.1    Moffitt, T.E.2    Cannon, M.3
  • 2
    • 0033066273 scopus 로고    scopus 로고
    • Antisocial personality disorder and substance abuse in schizophrenia and major affective disorders
    • Mueser KT, Rosenberg SD, Drake RE, Miles K, Wolford G, Carrieri K. Antisocial personality disorder and substance abuse in schizophrenia and major affective disorders. J Stud Alcohol. 1999;60:278-284.
    • (1999) J Stud Alcohol , vol.60 , pp. 278-284
    • Mueser, K.T.1    Rosenberg, S.D.2    Drake, R.E.3    Miles, K.4    Wolford, G.5    Carrieri, K.6
  • 3
    • 0030560972 scopus 로고    scopus 로고
    • Substance abuse and the onset of schizophrenia
    • Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry. 1996;40:1155-1163.
    • (1996) Biol Psychiatry , vol.40 , pp. 1155-1163
    • Hambrecht, M.1    Hafner, H.2
  • 4
    • 0033002549 scopus 로고    scopus 로고
    • Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?
    • Green AI, Zimmet SV, Strous RD, Schildkraut JJ. Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harv Rev Psychiatry. 1999;6:287-296.
    • (1999) Harv Rev Psychiatry , vol.6 , pp. 287-296
    • Green, A.I.1    Zimmet, S.V.2    Strous, R.D.3    Schildkraut, J.J.4
  • 5
    • 24944509682 scopus 로고    scopus 로고
    • Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism?
    • Roth RM, Brunette MF, Green AI. Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism? Curr Psychiatry Rep. 2005;7:283-291.
    • (2005) Curr Psychiatry Rep , vol.7 , pp. 283-291
    • Roth, R.M.1    Brunette, M.F.2    Green, A.I.3
  • 6
    • 0036196742 scopus 로고    scopus 로고
    • Psychosocial aspects of substance abuse by clients with severe mental illness
    • Drake RE, Wallach MA, Alverson HS, Mueser KT. Psychosocial aspects of substance abuse by clients with severe mental illness. J Nerv Ment Dis. 2002;190:100-106.
    • (2002) J Nerv Ment Dis , vol.190 , pp. 100-106
    • Drake, R.E.1    Wallach, M.A.2    Alverson, H.S.3    Mueser, K.T.4
  • 7
    • 34250747543 scopus 로고    scopus 로고
    • Psychosocial intervention research on co-occurring disorders
    • In press
    • Drake RE. Psychosocial intervention research on co-occurring disorders. J Dual Diagn. In press.
    • J Dual Diagn
    • Drake, R.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.